Shingles (Herpes Zoster) Vaccination

Shingles is a painful rash that usually develops on one side of the body, often the face or torso. The rash consists of blisters that typically scab over in 7 to 10 days and clears up within 2 to 4 weeks. Some people describe the pain as an intense burning sensation. For some people, the pain can last for months or even years after the rash goes away. This long-lasting pain is called postherpetic neuralgia (PHN), and it is the most common complication of shingles. Your risk of getting shingles and PHN increases as you get older.

Recombinant zoster vaccine (RZV, Shingrix) is licensed in the United States and recommended by the Advisory Committee on Immunization Practices (ACIP) to prevent shingles in adults 50 years and older.

crowd icon

What Everyone Should Know About the Shingles Vaccine

Basic information about the shingles vaccine

medical icon

Information for Healthcare Professionals

Vaccine recommendations and contraindications; composition, dosage, administration, and co-administration with other vaccines; Shingrix FAQ; storage and handling

doctor injecting vaccine dose in woman’s arm muscle.

Shingrix is recommended for adults 50 and older to prevent shingles and its complications.

Page last reviewed: July 1, 2019